Oric Pharmaceuticals, Inc. ORIC

13.16 (0.02) (0.15%) as of 25 Sep
Market cap
$1.4B
P/E
0.0×
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Current Ratio 10.20 16.84 16.81 32.96 15.88 13.68 10.39 10.56 14.13
Net Debt/EBITDA 1.19 1.99 3.24 4.03 3.09 2.25 1.80 1.71 1.95
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 40.78% 39.55% 34.80% (73.82%) (27.98%) (35.99%) (45.11%) (54.73%) (41.27%)
ROA (57.40%) 0.00% (57.14%) (37.50%) (26.34%) (32.66%) (40.34%) (48.60%) (37.91%)
ROIC 0.00% 0.00% 0.00% 0.00% (136.94%) (356.70%) (435.43%) 0.00% (86.88%)
Return on Tangible Assets (81.89%) (48.95%) (30.94%) (25.44%) (34.56%) (44.94%) (51.64%) (53.20%) (47.87%)
Free Cash Flow per Share (0.70) (12.23) (12.80) (2.09) (1.59) (1.95) (1.68) (1.63) (1.27)
Book value per Share 0.86 0.00 (47.44) 13.21 7.19 5.61 4.36 3.49 4.38
Free Cash Flow (20.83) (21.21) (24.30) (45.93) (60.48) (77.22) (86.54) (113.85) (111.68)
Other line items

Show all line items

Columns are period end dates